Arbutus Biopharma Corp (ABUS) Insider Trading

Name: Arbutus Biopharma Corp (ABUS) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Sep 24, 2026): Androski Lindsay (President and CEO): Exercise/Conversion of 116,408 shares, $372.5K.

Get alerted when insiders trade ABUS

Email address

Loading company data...

Beta

Loading company details...

Beta